motor neuron disease: A disease involving the motor neuron.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
674 |
4. Check minimum number of eventsNone |
674 |
5. Include endpointsNone |
674 |
6. Filter based on genotype QC (FinnGen only) |
674 |
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G12
- Name in latin
- Morbus motoneuronalis
Similar endpoints
↥List of similar endpoints to
Motor neuron disease
based on the number of shared cases.
Similar with more cases:
- Motor neuron disease (with DMD)
- Systemic atrophies primarily affecting the central nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8362 | 3928 | 4249 |
| Only index persons | 4490 | 2114 | 2376 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.11 | 0.12 |
| Only index persons | 0.08 | 0.08 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 66.30 | 67.33 | 65.35 |
| Only index persons | 67.14 | 68.36 | 66.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 674 | 269 | 405 |
| Unadjusted period prevalence (%) | 0.14 | 0.09 | 0.18 |
| Median age at first event (years) | 67.64 | 67.35 | 67.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 603
- Matched controls
- 6029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G12.2
ICD-10 Finland
Motor neuron disease
+∞
323.0
579
*
N07XX02
ATC
riluzole; oral
+∞
166.5
152
*
N99
ICPC
Neurological disease other
1665.9
140.3
131
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
67.8
130.7
149
29
R47.1
ICD-10 Finland
Dysarthria and anarthria
766.1
129.5
123
*
J96.1
ICD-10 Finland
Chronic respiratory failure
43.7
118.5
147
44
JDB10
NOMESCO Finland
Percutaneous gastrostomy
85.0
116.1
128
19
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
23.7
102.2
150
83
R13
ICD-10 Finland
Dysphagia
19.1
96.6
153
105
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
26.3
82.3
116
54
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
27.8
82.3
114
50
Z51.5
ICD-10 Finland
Palliative care
11.3
81.8
166
196
N28
ICPC
Limited function/disability (N)
131.3
75.9
80
7
TAB00
NOMESCO Finland
Lumbar puncture
51.0
66.8
80
18
R4130
NOMESCO Finland
Speech therapy
51.7
64.4
77
17
XG466
NOMESCO Finland
Sleep oxymetry
42.4
62.8
78
21
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
10.7
61.6
126
145
G47.3
ICD-10 Finland
Sleep apnoea
20.1
57.0
87
50
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
56.8
56.2
66
13
SPAT1229
SPAT
Assessment of need for aid
10.7
56.2
114
128
A28
ICPC
Limited function/disability NOS
6.0
54.5
171
373
L28
ICPC
Limited function/disability (L)
5.6
49.4
163
373
WX725
NOMESCO Finland
Noninvasive ventilation
11.6
48.3
93
93
R5140
NOMESCO Finland
Monitoring the use of the aid
14.4
47.9
83
66
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
+∞
46.4
44
*
AA1AD
NOMESCO Finland
CT of head and brain
5.6
41.8
135
296
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.8
41.0
157
415
N03AE01
ATC
clonazepam; systemic
16.0
40.0
66
46
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
412.7
39.5
39
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
109.7
38.2
41
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
12.0
38.0
71
66
R1260
NOMESCO Finland
Evaluation of communicative skills
37.2
35.5
45
13
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.5
34.0
84
127
N29
ICPC
Neurological sympt/complt other
53.3
33.9
40
8
R1250
NOMESCO Finland
Evaluation of functional capability
24.1
33.2
47
21
M03BX01
ATC
baclofen; systemic
57.7
32.6
38
7
N19
ICPC
Speech disorder
65.5
32.4
37
6
SPAT1216
SPAT
Assessment of functional ability
4.4
31.5
128
350
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
10.5
31.2
62
65
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
15.8
31.1
51
35
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
6.9
30.4
79
128
S06.0
ICD-10 Finland
Concussion
19.0
30.1
46
26
SPAT1231
SPAT
Assessment of adjustments needed in living environment
20.0
28.7
43
23
R5599
NOMESCO Finland
Other rehabilitation service
13.5
28.6
50
40
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
25.9
28.2
39
16
R4120
NOMESCO Finland
Occupational therapy
7.7
28.0
67
96
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
105.0
27.9
30
*
R4190
NOMESCO Finland
Nutritional therapy
11.3
27.8
53
51
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
31.8
27.5
36
12
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
7.3
26.6
66
100
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
+∞
26.2
25
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
17.5
26.2
41
25
N18
ICPC
Paralysis/weakness
42.1
26.1
32
8
D21
ICPC
Swallowing problem
24.7
25.0
35
15
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
36.2
24.5
31
9
G72.9
ICD-10 Finland
Myopathy, unspecified
249.2
23.8
24
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
23.5
110
337
SPAT1215
SPAT
Assessment of need for medical rehabilitation
9.3
23.3
49
57
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
+∞
23.1
22
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.6
23.0
113
359
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.6
22.4
49
61
N05AH04
ATC
quetiapine; oral
6.8
21.3
55
88
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.6
21.3
56
92
XA402
NOMESCO Finland
ENMG
15.8
20.4
33
22
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
13.7
20.4
35
27
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
33.8
20.3
26
8
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
33.8
20.3
26
8
SPAT1245
SPAT
Provision of support and information to patient’s family members
7.8
19.8
46
63
R25.3
ICD-10 Finland
Fasciculation
76.0
19.8
22
*
SPAT1234
SPAT
Support of social functional capacity
8.0
19.7
45
60
N06AX11
ATC
mirtazapine; oral
2.8
19.5
149
640
N05BA04
ATC
oxazepam; oral
3.0
19.4
128
501
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
19.3
189
935
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
18.8
18
*
XA800
NOMESCO Finland
Neuropsychological investigation
24.6
18.8
26
11
N06AB10
ATC
escitalopram; oral
3.7
18.8
87
262
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
9.6
18.6
38
42
G56.0
ICD-10 Finland
Carpal tunnel syndrome
10.6
18.6
36
36
N03AX12
ATC
gabapentin; oral
3.6
18.5
88
271
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
17.8
17
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
17.8
17
*
XG416
NOMESCO Finland
Measurement of maximal airway pressure
+∞
17.8
17
*
Z50.5
ICD-10 Finland
Speech therapy
37.9
17.7
22
6
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
97.9
17.6
19
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
17.6
161
761
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
17.3
161
767
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
17.1
170
835
N06AB04
ATC
citalopram; systemic
3.3
17.1
94
322
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
16.7
16
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.2
16.6
31
29
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.8
16.6
56
125
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
9.2
16.4
34
39
SPAT1254
SPAT
Administration of medicine
3.1
16.0
93
330
3352A
ICD-9 Finland
Anterior horn cell disease, Motor neuron disease[SCLEROSIS LATERALIS AMYOTROPHICA]
+∞
15.7
15
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
15.7
15
*
NXL00
NOMESCO Finland
Biopsy of muscle
87.3
15.6
17
*
G56.2
ICD-10 Finland
Lesion of ulnar nerve
163.9
15.5
16
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
32.6
14.9
19
6
XX9TE
NOMESCO Finland
Compementary ultrasound examination
32.6
14.9
19
6
F80.1
ICD-10 Finland
Expressive language disorder
82.1
14.6
16
*
GX2D5
NOMESCO Finland
Sleep oximetry
153.4
14.5
15
*
A06AD11
ATC
lactulose; oral
2.8
14.5
98
386
T05
ICPC
Feeding problem of adult
27.9
14.3
19
7
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
14.3
74
243
N02AA01
ATC
morphine; systemic, rectal
7.5
14.2
33
46
ACC51
NOMESCO Finland
Release of median nerve
43.6
14.2
17
*
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
54.6
13.9
16
*
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
13.6
13
*
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
13.6
13
*
G20
ICD-10 Finland
Parkinson disease
142.9
13.5
14
*
N05AX08
ATC
risperidone; systemic
18.7
13.4
20
11
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
26.4
13.4
18
7
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
21.7
13.4
19
9
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
23.1
12.9
18
8
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
71.3
12.6
14
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
71.3
12.6
14
*
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
12.5
12
*
N05BA06
ATC
lorazepam; systemic, sublingual
5.3
12.3
37
73
Z31.5
ICD-10 Finland
Genetic counselling
5.6
12.1
35
66
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
11.4
12.1
22
20
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
18.5
12.1
18
10
N03AG01
ATC
valproic acid; systemic, rectal
21.8
12.1
17
8
S01.0
ICD-10 Finland
Open wound of scalp
4.0
11.6
47
126
RS314
NOMESCO Finland
NA
+∞
11.5
11
*
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
122.1
11.5
12
*
M62.5
ICD-10 Finland
Muscle wasting and atrophy, not elsewhere classified
122.1
11.5
12
*
K90
ICPC
Stroke/cerebrovascular accident
122.1
11.5
12
*
RS340
NOMESCO Finland
NA
122.1
11.5
12
*
N05BA01
ATC
diazepam; systemic, rectal
3.0
11.4
67
240
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
10.8
11.3
21
20
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
25.5
11.2
15
6
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
20.5
11.2
16
8
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.9
11.1
45
121
G62.8
ICD-10 Finland
Other specified polyneuropathies
44.1
10.9
13
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
15.8
10.9
17
11
WX722
NOMESCO Finland
PEEP
7.4
10.8
25
35
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
21.9
10.7
15
7
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
14.5
10.5
17
12
N03AF01
ATC
carbamazepine; oral, rectal
7.0
10.5
25
37
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
10.4
10
*
RS310
NOMESCO Finland
NA
+∞
10.4
10
*
N07AA02
ATC
pyridostigmine; systemic
+∞
10.4
10
*
N05AN01
ATC
lithium; oral
+∞
10.4
10
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
+∞
10.4
10
*
XA421
NOMESCO Finland
Nocturnal polygraphy
+∞
10.4
10
*
N06AA09
ATC
amitriptyline; systemic
3.6
10.4
46
134
UJC01
NOMESCO Finland
Scopy of lower throat
10.8
10.3
19
18
R53
ICD-10 Finland
Malaise and fatigue
2.5
10.3
88
391
A98
ICPC
Health maint/preventive medicine
0.5
10.1
421
4901
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
9.8
48
152
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
13.6
9.7
16
12
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.3
9.6
35
86
R06.0
ICD-10 Finland
Dyspnoea
2.0
9.5
136
762
R47.0
ICD-10 Finland
Dysphasia and aphasia
101.5
9.4
10
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
17.9
9.4
14
8
N06DA02
ATC
donepezil; oral
17.9
9.4
14
8
A120_
NOMESCO Finland
NA
+∞
9.4
9
*
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
+∞
9.4
9
*
A210_
NOMESCO Finland
NA
+∞
9.4
9
*
SPAT1240
SPAT
Therapeutic discussion
4.0
9.4
36
93
J96.0
ICD-10 Finland
Acute respiratory failure
8.9
9.3
19
22
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.0
9.3
36
94
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
13.9
9.2
15
11
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
37.2
9.0
11
*
R49.08
ICD-10 Finland
Other specified dysphonia
7.6
9.0
20
27
N05AH03
ATC
olanzapine; systemic
18.9
9.0
13
7
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
12.8
8.9
15
12
R5110
SPAT
NA
5.8
8.8
24
43
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
14.3
8.7
14
10
RS122
NOMESCO Finland
NA
50.7
8.7
10
*
N87
ICPC
Parkinsonism
50.7
8.7
10
*
SPAT1262
SPAT
Handing over of treatment supplies
2.1
8.7
105
552
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
8.6
102
530
WYA20
NOMESCO Finland
Home visit
16.6
8.6
13
8
N06AX21
ATC
duloxetine; oral
3.8
8.6
35
96
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
8.3
8
*
K11.72
ICD-10 Finland
Xerostomia
+∞
8.3
8
*
Z93.1
ICD-10 Finland
Gastrostomy status
+∞
8.3
8
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
+∞
8.3
8
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
8.3
8
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
8.3
8
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
8.3
8
*
N03AF02
ATC
oxcarbazepine; oral
+∞
8.3
8
*
N81
ICPC
Injury nervous system other
+∞
8.3
8
*
TNX05
NOMESCO Finland
Simple incision of soft tissue, unspecified region
+∞
8.3
8
*
L99
ICPC
Musculoskeletal disease other
8.7
8.3
17
20
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
8.3
88
436
M48.0
ICD-10 Finland
Spinal stenosis
2.5
8.3
66
284
XG410
NOMESCO Finland
Flow-volume spirometry
3.9
8.3
33
89
RS230
NOMESCO Finland
NA
22.3
8.0
11
5
F06.7
ICD-10 Finland
Mild cognitive disorder
22.3
8.0
11
5
U04
ICPC
Incontinence urine
4.0
8.0
30
77
W19
ICD-10 Finland
Unspecified fall
3.0
7.9
45
159
Z50.1
ICD-10 Finland
Other physical therapy
3.4
7.8
37
115
RS221
NOMESCO Finland
NA
9.6
7.8
15
16
R06.5
ICD-10 Finland
Mouth breathing
3.9
7.8
30
79
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
45.5
7.7
9
*
WX723
NOMESCO Finland
CPAP therapy
45.5
7.7
9
*
RS311
NOMESCO Finland
NA
45.5
7.7
9
*
J96.9
ICD-10 Finland
Respiratory failure, unspecified
18.6
7.6
11
6
130
Kela drug reimbursment
Malignant tumour
0.2
7.6
10
404
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.9
7.5
23
48
N02AA05
ATC
oxycodone; systemic
2.1
7.5
92
484
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.7
7.5
31
87
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.5
7.3
15
18
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
+∞
7.3
7
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
7.3
7
*
A220_
NOMESCO Finland
NA
+∞
7.3
7
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
+∞
7.3
7
*
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
+∞
7.3
7
*
N05AX12
ATC
aripiprazole; systemic
+∞
7.3
7
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
+∞
7.3
7
*
34800
ICD-8 Finland
Motor neurone disease, Amyotrophic lateral sclerosis
+∞
7.3
7
*
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
7.3
7
*
G12.0
ICD-10 Finland
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
+∞
7.3
7
*
G72.8
ICD-10 Finland
Other specified myopathies
+∞
7.3
7
*
R42
ICD-10 Finland
Dizziness and giddiness
2.0
7.3
93
499
SPAT1139
SPAT
Nutrition survey
4.7
7.3
23
50
SPAT1167
SPAT
Insertion of urinary catheter
3.9
7.1
28
75
Z73.6
ICD-10 Finland
Limitation of activities due to disability
12.2
7.1
12
10
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
40.5
6.8
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
6.7
223
1612
N05CF01
ATC
zopiclone; oral
1.7
6.7
154
1008
R41.0
ICD-10 Finland
Disorientation, unspecified
8.8
6.6
13
15
RK110
NOMESCO Finland
NA
10.2
6.6
12
12
L19
ICPC
Muscle symptom/complaint NOS
5.1
6.5
19
38
N03AX16
ATC
pregabalin; oral
1.9
6.5
96
540
JDB00
NOMESCO Finland
Gastrostomy
70.5
6.4
7
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
70.5
6.4
7
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
70.5
6.4
7
*
F34.1
ICD-10 Finland
Dysthymia
70.5
6.4
7
*
N04BC05
ATC
pramipexole; oral
3.1
6.4
33
111
RS222
NOMESCO Finland
NA
8.3
6.4
13
16
N06AX16
ATC
venlafaxine; oral
3.2
6.3
31
101
Z75.5
ICD-10 Finland
Holiday relief care
18.2
6.3
9
5
RS313
NOMESCO Finland
NA
18.2
6.3
9
5
N86
ICPC
Multiple sclerosis
+∞
6.3
6
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
6.3
6
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
6.3
6
*
K91
ICPC
Cerebrovascular disease
+∞
6.3
6
*
N04BD01
ATC
selegiline; oral
+∞
6.3
6
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
+∞
6.3
6
*
WPA13
NOMESCO Finland
Palliative consultation
+∞
6.3
6
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
6.3
6
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
6.3
6
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
+∞
6.3
6
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
6.3
6
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
+∞
6.3
6
*
G45.4
ICD-10 Finland
Transient global amnesia
+∞
6.3
6
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
6.3
6
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
6.3
6
*
N06AX26
ATC
vortioxetine; oral
7.1
6.2
14
20
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
26.9
6.2
8
*
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
6.8
6.1
14
21
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
6.0
61
296
P29
ICPC
Psychological sympt/compl other
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
67
12
61.89
119.75
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
64
11
64.18
115.16
1.0
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
75
26
32.33
113.98
1.1
1.0
e6/l
9.2
226.5
0.47
61
18
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
74
26
31.85
111.94
1.2
1.0
e6/l
724.1
164.1
0.41
61
19
(3044290) Cell count panel - Cerebral spinal fluid
74
28
29.56
109.19
1.1
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
341
1092
5.30
101.88
2.5
1.7
u/l
246.9
195.5
1.01
325
1004
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
135
199
8.23
90.74
4.9
3.8
mmol/l
3.5
1.7
4.81
125
148
(3009343) pH of Capillary blood
139
212
8.00
90.68
5.1
3.8
ph
7.4
7.4
1.92
19
27
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
140
217
7.88
90.01
5.2
3.8
kpa
5.7
5.0
10.73
134
195
(3019060) Gas panel - Arterial blood
141
277
6.17
71.34
3.1
4.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
68
8
94.45
62.22
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
66
9
80.91
59.27
1.1
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
94
150
7.12
57.94
5.7
3.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
76
100
8.44
55.44
5.4
3.7
mmol/l
28.3
24.6
5.43
66
84
(3004588) Protein electrophoresis panel - Serum or Plasma
115
277
4.80
45.27
1.3
2.7
—
—
—
0
0
(4027681)
49
6
88.02
44.50
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
59
79
8.09
42.21
5.5
4.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
128
357
4.19
41.56
1.6
2.7
g/l
67.8
66.4
1.68
117
329
(3023410) Appearance of Cerebral spinal fluid
28
13
22.43
37.63
1.3
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
154
524
3.51
37.21
5.5
7.1
kpa
5.8
5.1
6.93
149
495
(3027801) Oxygen [Partial pressure] in Arterial blood
153
524
3.48
36.54
5.5
7.1
kpa
10.5
12.5
8.70
147
495
(3021901) Oxygen saturation in Capillary blood
53
76
7.48
35.66
4.2
3.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
148
522
3.35
33.51
5.5
7.1
mmol/l
4.1
0.8
18.11
128
407
(3016018) Differential panel - Cerebral spinal fluid
27
16
17.54
32.55
1.2
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
150
5.01
30.36
1.3
1.9
g/l
2.7
3.2
4.02
46
125
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
162
4.78
29.48
1.3
1.9
g/l
3.6
3.7
0.15
46
121
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
162
4.78
29.48
1.3
1.9
g/l
6.5
7.5
4.43
46
124
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
162
4.78
29.48
1.3
1.9
—
—
—
0
0
(3020891) Body temperature
67
151
4.82
28.21
4.2
3.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
157
4.71
27.80
1.1
1.9
g/l
10.2
10.6
0.40
47
135
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
399
5187
0.43
23.49
3.6
4.8
mmol/l
2.8
2.7
0.98
335
4701
(3005719) IgG [Mass/volume] in Serum or Plasma
85
266
3.51
22.84
1.6
3.4
g/l
10.5
11.0
0.47
72
251
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
387
5069
0.44
22.57
3.4
4.2
mmol/l
4.8
4.6
1.48
325
4629
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
385
5027
0.45
21.48
3.5
4.2
mmol/l
1.5
1.5
0.41
325
4559
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
53
124
4.55
21.25
1.7
2.4
ug/l
197.3
323.7
0.88
47
116
(3017569) Oxygen content in Arterial blood
23
23
10.32
20.36
1.9
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
377
4856
0.49
17.51
3.2
3.8
mmol/l
1.2
1.2
0.03
318
4365
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
48
123
4.12
17.10
1.3
1.7
g/l
0.0
0.0
0.50
43
111
(3019309) Folate [Moles/volume] in Red Blood Cells
155
778
2.29
16.68
1.7
1.7
nmol/l
1168.2
1165.3
0.01
123
571
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
49
131
3.96
16.48
1.1
1.6
g/l
40.0
37.2
2.56
43
114
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
46
121
4.01
15.82
1.1
1.7
g/l
0.0
0.0
0.00
41
109
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
50
141
3.75
15.60
1.4
2.0
g/l
0.2
1.7
1.81
43
119
(40767503) Oxygen content in Capillary blood by calculation
37
83
4.66
15.59
2.6
2.5
%
18.4
15.8
3.72
27
45
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
368
4711
0.52
15.29
4.7
5.6
mmol/mol
38.6
39.9
2.26
325
4300
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
45
120
3.95
15.19
1.1
1.7
g/l
0.0
0.0
0.00
40
109
(3006653) Thiamine [Moles/volume] in Blood
19
7
27.86
14.34
1.0
1.1
nmol/l
132.7
147.1
—
19
7
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
142
733
2.19
14.06
1.8
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
406
4986
0.53
13.50
3.9
4.4
mmol/l
5.9
6.0
0.67
360
4466
(3024561) Albumin [Mass/volume] in Serum or Plasma
293
1982
1.85
13.21
3.5
4.8
g/l
35.5
34.9
1.00
276
1838
(3037522) Nuclear Ab [Titer] in Serum
99
462
2.34
12.40
1.3
1.3
titre
676.7
406.3
0.57
24
102
(3019977) pH of Arterial blood
17
22
7.90
12.33
1.5
2.0
ph
7.4
7.4
—
12
9
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
394
4830
0.56
11.97
14.0
12.6
ml/min/173m2
91.9
75.6
27.43
325
3885
(3010813) Leukocytes [#/volume] in Blood
493
5652
0.52
11.55
23.0
18.6
e9/l
6.7
6.6
0.20
478
5428
(3000963) Hemoglobin [Mass/volume] in Blood
494
5654
0.53
11.33
23.1
18.7
g/l
135.2
135.8
0.49
489
5538
(3026361) Erythrocytes [#/volume] in Blood
494
5652
0.53
11.26
23.0
18.6
e12/l
4.4
4.5
1.52
478
5430
(3035941) MCH [Entitic mass]
494
5651
0.53
11.22
22.9
18.5
pg
30.6
30.5
0.61
487
5530
(3024731) MCV [Entitic volume]
494
5651
0.53
11.22
22.9
18.5
fl
91.9
91.5
1.11
487
5530
(3007461) Platelets [#/volume] in Blood
494
5649
0.53
11.15
23.0
18.6
e9/l
244.9
240.9
0.82
481
5444
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
89
3.85
10.98
2.4
2.1
g/l
141.6
128.9
2.21
28
61
(3044927) Protein electrophoresis panel - Urine
22
43
5.26
10.85
1.1
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
316
2280
1.73
10.78
5.5
6.3
mmol/l
1.2
1.2
4.33
260
1938
(3012095) Magnesium [Moles/volume] in Serum or Plasma
125
685
2.01
10.35
2.4
3.3
mmol/l
0.8
0.8
0.35
106
635
(40768804) Tissue Pathology biopsy report
125
2067
0.51
10.18
2.2
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
474
5444
0.56
9.79
9.8
9.5
u/l
28.8
25.4
4.49
457
5189
(3032080) INR in Blood by Coagulation assay
279
1989
1.69
9.64
8.6
9.2
inr
1.2
1.3
1.28
64
515
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
284
2067
1.65
8.86
5.7
5.5
mmol/l
1.2
1.2
0.91
255
1855
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
10
10.14
8.66
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
380
4562
0.62
8.42
18.3
14.1
%
38.9
39.4
0.36
225
3149
(3044889) 12 lead EKG panel
286
3651
0.62
8.13
3.0
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
95
515
1.98
8.02
1.9
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
194
1310
1.68
7.93
3.4
2.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
107
1745
0.54
7.87
2.6
2.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
346
2699
1.58
7.77
4.9
4.1
mmol/l
6.5
6.8
2.50
331
2521
(46235355) HIV 1 and 2 tests - Meaningful Use set
82
427
2.05
7.74
1.3
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
99
1638
0.54
7.60
3.0
3.8
mg/mmol
10.9
7.3
0.43
53
1042
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
93
517
1.93
7.29
1.8
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
147
945
1.71
7.14
1.4
1.7
pmol/l
451.7
26873800.4
1.04
122
774
(3003129) Base excess in Capillary blood by calculation
10
6
16.89
6.76
1.4
2.0
mmol/l
5.6
4.3
—
10
6
(3006315) Basophils [#/volume] in Blood
292
2248
1.53
6.60
5.0
5.3
e9/l
0.0
0.0
2.01
257
1868
(3001604) Monocytes [#/volume] in Blood
290
2240
1.52
6.40
5.0
5.3
e9/l
0.5
0.6
2.93
256
1862
(3028717) Thiamine [Mass/volume] in Blood
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
92
1481
0.56
6.22
2.5
3.3
ug/l
0.8
0.9
0.16
66
1029
(3013115) Eosinophils [#/volume] in Blood
297
2331
1.49
5.94
5.2
5.4
e9/l
0.2
0.2
3.20
265
1979
(40761511) CBC panel - Blood by Automated count
467
5231
0.65
5.88
15.2
11.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
359
4234
0.67
5.86
21.9
16.8
g/l
332.6
332.5
0.13
353
4187
(3009508) Creatinine [Moles/volume] in Urine
100
1549
0.58
5.80
2.4
3.0
mmol/l
7.7
7.5
0.17
72
1279
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
70
3.22
5.79
1.2
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
76
427
1.88
5.76
3.4
3.4
mmol/l
4.8
1.7
6.67
61
319
(3019198) Lymphocytes [#/volume] in Blood
293
2309
1.48
5.66
5.0
5.3
e9/l
2.1
1.8
0.25
263
1973
(3002256) Pathology report gross observation
33
713
0.44
5.39
1.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
179
1287
1.53
5.35
3.9
4.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
40
183
2.26
5.27
1.6
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
205
1529
1.49
5.11
4.6
5.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
51
261
2.03
5.07
6.7
9.7
mmol/l
27.2
24.6
6.83
44
244
(3023419) Bacteria identified in Sputum by Culture
17
50
3.46
5.05
2.8
2.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
250
1948
1.45
4.96
1.8
1.9
pmol/l
94.4
94.2
0.02
139
977
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
35
159
2.27
4.70
1.6
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
266
0.26
4.66
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
105
1531
0.63
4.59
2.3
3.1
mg/l
11376.1
142.2
4.58
64
984
(3023103) Potassium [Moles/volume] in Serum or Plasma
484
5315
0.68
4.53
18.8
15.0
mmol/l
3.9
4.0
7.44
472
5136
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
117
2.45
4.53
1.4
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
88
555
1.67
4.51
3.5
5.3
mmol/l
1.0
1.0
0.83
78
510
(3019550) Sodium [Moles/volume] in Serum or Plasma
483
5302
0.69
4.46
19.0
14.8
mmol/l
139.7
139.7
0.07
475
5131
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
50
267
1.94
4.44
10.2
9.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
268
2154
1.41
4.34
4.9
5.7
%
8.2
9.1
4.96
254
1991
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
6
11.77
4.28
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
6
11.77
4.28
1.1
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
6
11.77
4.28
1.3
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
266
2142
1.40
4.23
4.7
5.5
%
2.5
2.9
2.49
250
1973
(3022096) Basophils/100 leukocytes in Blood
260
2088
1.40
4.20
4.6
5.5
%
0.6
0.7
1.11
246
1925
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
23
4.40
4.10
1.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
10
8.08
4.07
4.5
4.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
7
10.09
4.02
1.1
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
7
10.09
4.02
1.1
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
532
0.45
3.93
1.2
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
113
2.35
3.89
1.7
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
270
2210
1.37
3.79
4.8
5.7
%
25.8
27.2
1.21
254
2039
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
298
1.81
3.75
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
77
495
1.63
3.68
4.5
2.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
176
1348
1.41
3.66
2.7
4.0
ph
7.4
7.4
0.18
29
227
(40768800) Prostate Pathology biopsy report
5
198
0.25
3.58
1.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
195
2422
0.73
3.47
3.8
5.5
ug/l
6.6
3.8
0.42
166
2178
(3014111) Lactate [Moles/volume] in Serum or Plasma
64
399
1.67
3.45
7.3
7.3
mmol/l
1.1
1.3
1.81
59
390
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
177
1372
1.39
3.41
2.9
3.1
u/l
36.1
37.6
0.09
171
1301
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
156
2001
0.71
3.37
3.8
4.6
%
22.2
21.9
0.10
81
1089
(3018010) Neutrophils/100 leukocytes in Blood
262
2173
1.34
3.26
4.7
5.4
%
59.4
57.5
1.81
249
2014
(40760892) CBC W Ordered Manual Differential panel - Blood
128
945
1.44
3.23
3.6
3.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
11
6.42
3.19
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
79
2.45
3.16
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
14
339
0.40
3.07
1.1
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
294
1.72
3.06
1.7
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
31
3.26
2.78
1.1
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
6
8.38
2.75
1.0
1.0
%
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
190
2303
0.76
2.70
5.3
4.4
estimate
0.0
0.0
0.00
39
389
(3026493) Urate [Moles/volume] in Serum or Plasma
96
1293
0.70
2.69
2.9
2.6
umol/l
11700.1
8976.0
0.16
81
1120
(3007853) Bacteria identified in Skin by Aerobe culture
69
469
1.52
2.64
2.2
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
609
0.58
2.63
2.8
4.9
ug/l
15.8
44.8
0.78
30
512
(3036481) Cortisol [Moles/volume] in Serum or Plasma
47
292
1.66
2.62
1.5
2.4
nmol/l
423.6
395.0
0.49
40
267
(3028707) Methadone [Presence] in Urine by Screen method
5
7
7.19
2.55
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
7
7.19
2.55
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
11
5.49
2.55
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
11
5.49
2.55
1.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
11
5.49
2.55
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
11
5.49
2.55
1.0
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
47
296
1.63
2.49
9.7
9.2
%
90.9
94.5
1.81
47
296
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
26
3.49
2.49
1.4
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
16
4.41
2.48
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
398
0.51
2.43
1.6
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
20
97
2.09
2.39
1.5
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
58
2.44
2.38
1.9
3.2
e9/l
3.9
4.0
0.12
14
58
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
22
3.67
2.37
2.1
4.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
182
1493
1.30
2.32
2.7
3.9
mmol/l
2.4
2.4
1.15
160
1280
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
13
4.65
2.27
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
204
1703
1.28
2.27
4.3
3.1
ng/l
65.6
69.1
0.06
183
1194
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
488
0.58
2.26
1.4
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
18
3.92
2.25
2.7
2.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
36
218
1.69
2.23
3.4
3.9
mmol/l
27.1
23.7
5.22
31
197
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
60
2.36
2.23
2.0
3.6
%
60.6
56.5
0.68
14
60
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
122
1.92
2.18
1.4
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
81
1084
0.71
2.17
4.1
2.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
198
2334
0.79
2.16
3.9
3.1
estimate
0.0
0.0
0.00
39
383
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
14
4.31
2.15
1.3
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
30
3.03
2.15
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
30
3.03
2.15
1.8
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
194
2283
0.79
2.07
4.0
3.1
estimate
0.0
0.0
0.00
39
379
(3001019) Free T4 and TSH panel - Serum or Plasma
6
159
0.37
2.04
1.0
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
15
4.03
2.04
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
15
4.03
2.04
1.7
2.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
50
2.43
2.03
1.1
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
50
2.43
2.03
1.1
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
50
2.43
2.03
1.1
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
90
2.03
2.02
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
90
2.03
2.02
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
26
3.10
2.02
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
386
3510
1.23
1.95
3.9
3.7
mm/h
10.8
13.5
4.08
360
3194
(3004451) EKG impression Narrative
6
16
3.77
1.94
1.2
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
85
2.03
1.91
1.7
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
309
1.52
1.91
2.7
3.4
ng/l
75.9
95.2
0.91
39
273
(4010399)
47
318
1.51
1.89
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
122
1.83
1.86
1.4
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
303
2698
1.22
1.84
6.6
8.9
e9/l
4.1
4.1
0.01
268
2281
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
29
2.78
1.79
1.1
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
29
2.78
1.79
1.1
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
29
2.78
1.79
1.1
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
29
2.78
1.79
1.1
1.7
—
—
—
0
0
(3019225) pH of Specimen
64
468
1.41
1.75
3.7
3.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
36
2.52
1.74
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
48
333
1.48
1.73
1.4
1.4
%
1.5
1.4
0.23
41
283
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
8
30
2.69
1.73
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
118
1.80
1.72
1.5
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
13
3.87
1.72
1.2
2.3
ug/l
61.3
56.8
—
5
13
(3031040) Bacteria [#/volume] in Urine by Automated count
340
3077
1.21
1.71
5.3
3.9
e6/l
52.0
1990.0
—
7
40
(3044242) Glucose [Moles/volume] in Arterial blood
7
25
2.82
1.65
2.0
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
49
2.27
1.64
1.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
49
2.27
1.64
2.3
1.9
%
89.0
89.8
0.17
11
49
(3052851) Hemolysis interference index of Serum or Plasma
22
128
1.74
1.62
2.7
3.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
5
125
0.40
1.51
1.6
3.3
u/ml
14.4
357.5
—
5
117
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.51
1.2
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
21
2.87
1.51
1.2
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
21
2.87
1.51
1.2
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
80
1.89
1.45
1.5
1.1
—
—
—
0
0
(4062490)
7
28
2.52
1.45
1.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
22
2.74
1.43
1.3
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
39
2.32
1.43
2.8
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
628
0.71
1.42
1.1
1.2
u/ml
11.7
20.3
0.53
17
230
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
165
1.60
1.42
1.9
2.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
37
255
1.48
1.41
1.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
46
2.19
1.40
1.2
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
54
401
1.38
1.39
9.1
8.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
89
1.82
1.38
1.5
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
17
2.95
1.36
1.2
3.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
37
0.00
1.34
0.0
1.8
—
3.0
—
0
31
(3000034) Microalbumin [Mass/volume] in Urine
0
38
0.00
1.34
0.0
3.1
—
13.3
—
0
31
(3000764) Benzodiazepines [Presence] in Urine
9
42
2.16
1.34
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
207
0.52
1.33
2.4
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
43
2.11
1.30
1.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
18
2.79
1.28
1.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
44
2.06
1.27
3.4
2.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
44
2.06
1.27
1.2
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
77
1.84
1.26
1.9
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
219
2444
0.85
1.24
2.8
2.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
305
2790
1.17
1.24
3.3
2.6
u/l
39.9
52.4
3.17
285
2532
(3004616) Nuclear Ab [Presence] in Serum
9
45
2.01
1.23
1.0
1.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
19
2.64
1.22
1.6
2.2
e9/l
0.2
0.2
—
5
19
(3039443) Prostate specific Ag panel - Serum or Plasma
7
143
0.48
1.22
1.4
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
26
379
0.67
1.18
1.7
1.9
nmol/l
11.9
12.6
0.18
21
335
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.5
—
1.0
—
0
33
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
72
1.82
1.15
1.8
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
80
1.77
1.13
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
88
1.72
1.12
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
16
96
1.68
1.11
1.0
1.1
—
14.3
—
0
6
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
66
1.83
1.09
1.9
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
124
1063
1.20
1.07
1.4
1.5
nmol/l
20.6
20.6
0.01
114
876
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
268
2456
1.15
1.02
5.0
6.7
umol/l
11.5
12.5
1.23
256
2321
(3003694) ABO and Rh group [Type] in Blood
114
1323
0.83
1.00
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
211
0.61
0.98
1.5
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
33
439
0.74
0.92
2.8
2.3
u/l
29.3
48.5
1.11
26
381
(3037121) Protein [Mass/volume] in Urine
23
159
1.46
0.92
3.8
3.3
g/l
0.2
0.2
—
10
72
(36660697) Celiac disease serology panel - Serum
36
271
1.35
0.91
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
43
1.87
0.87
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
43
1.87
0.87
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
251
0.67
0.86
3.4
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
297
0.70
0.86
4.4
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
115
0.52
0.83
1.0
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
32
1.88
0.82
2.5
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
32
416
0.76
0.79
1.9
2.3
ug/g
118.1
146.8
0.31
27
330
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
26
0.00
0.78
0.0
5.8
—
71.6
—
0
5
(3017732) Neutrophils [#/volume] in Blood
36
279
1.31
0.77
2.1
2.3
e9/l
4.5
4.2
0.24
27
206
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
279
0.71
0.77
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
199
2168
0.88
0.76
8.2
8.7
e9/l
0.0
0.0
1.55
163
1741
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
88
757
1.19
0.76
1.2
1.2
u/ml
0.7
1.3
1.42
16
193
(3004789) Transferrin [Mass/volume] in Serum or Plasma
56
675
0.81
0.75
1.7
2.3
g/l
2.2
2.2
0.48
49
632
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
103
899
1.17
0.75
1.8
1.5
mg/l
1.3
1.5
0.39
85
700
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
160
1763
0.88
0.73
4.2
3.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
2.8
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
2.8
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
109
0.55
0.72
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
41
1.71
0.70
1.1
1.2
—
—
—
0
0
(44806118)
9
58
1.56
0.70
1.4
1.7
—
—
—
0
0
(44790049)
9
58
1.56
0.70
1.4
1.7
—
—
—
0
0
(44790048)
9
58
1.56
0.70
1.4
1.7
—
—
—
0
0
(44790047)
9
58
1.56
0.70
1.4
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.8
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
119
0.58
0.68
2.3
4.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
111
1245
0.87
0.66
3.8
3.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
106
939
1.15
0.65
3.4
3.6
ng/l
891.4
517.6
0.19
92
799
(3019230) Fractional oxyhemoglobin in Venous blood
14
95
1.48
0.64
4.9
3.1
%
72.0
62.8
1.25
14
95
(4094501)
8
130
0.61
0.64
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
190
1752
1.12
0.63
1.9
2.1
nmol/l
77.9
79.5
0.30
162
1533
(4146454)
8
49
1.64
0.62
1.6
2.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
14
198
0.70
0.61
1.0
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
44
363
1.23
0.60
2.5
3.3
mmol/l
1.2
1.2
0.92
35
317
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
35
1.72
0.58
1.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
35
1.72
0.58
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
1.9
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
476
4900
0.90
0.57
17.0
12.5
mg/l
25.7
28.2
0.73
412
3716
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
86
0.58
0.56
1.6
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.8
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
237
0.75
0.52
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
17
126
1.36
0.52
2.1
1.8
s
20.1
22.6
1.56
12
113
(3013512) EKG study
137
1490
0.90
0.51
3.5
3.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
106
0.66
0.49
1.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
45
1.56
0.49
1.0
1.0
—
10.7
—
0
5
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
350
3363
1.08
0.48
3.3
3.3
pmol/l
15.2
15.0
1.15
326
2992
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
56
640
0.86
0.46
1.8
2.3
%
22.5
22.9
0.08
50
557
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
82
0.61
0.46
2.4
6.3
—
429.9
—
0
12
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
51
1.38
0.44
1.1
1.1
—
—
—
0
0
(4035726)
42
489
0.85
0.44
1.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
92
0.65
0.42
1.2
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
70
1.44
0.42
1.7
1.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
17
0.00
0.40
0.0
7.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
399
0.84
0.40
2.0
2.8
ml/min/173m2
128.5
59.0
0.71
11
151
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
19
0.00
0.39
0.0
1.1
—
7.4
—
0
19
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
69
620
1.13
0.38
7.8
6.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
66
1.37
0.38
4.3
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
66
1.37
0.38
1.2
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
5
36
1.39
0.38
1.0
1.5
—
100.0
—
0
6
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
105
1138
0.91
0.38
2.1
2.0
mg/l
3.3
2.9
0.74
85
962
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
70
1.29
0.36
3.1
2.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
93
854
1.10
0.36
3.0
3.5
mmol/l
2.5
2.5
0.45
78
745
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
255
0.82
0.35
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
73
663
1.11
0.35
1.2
1.2
iu/ml
39.1
46.3
0.11
19
203
(3002582) Erythrocytes [#/volume] in Urine
155
1461
1.08
0.34
3.5
3.3
e6/l
52.7
81.9
0.49
121
1116
(3000492) Spirometry study
46
407
1.14
0.33
1.8
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
6
90
0.66
0.33
3.0
4.3
%
1.0
1.8
—
6
64
(40768795) Lymph node Pathology biopsy report
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
2.6
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
169
1777
0.93
0.30
2.3
2.5
ug/l
150.2
171.5
0.79
154
1623
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
56
1.25
0.29
2.3
4.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
41
364
1.13
0.29
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
45
502
0.89
0.29
2.4
2.5
umol/l
8.1
9.4
0.25
40
445
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
130
1376
0.93
0.28
2.3
2.3
u/l
52.2
60.2
2.46
119
1242
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
417
0.88
0.28
1.5
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
76
1.32
0.28
1.1
1.8
ug/l
14.3
27.9
—
10
76
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
63
1.27
0.28
1.1
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
183
1750
1.06
0.27
3.7
3.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
150
0.80
0.27
1.5
4.0
—
1.1
—
0
10
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
830
0.92
0.27
2.9
3.0
e6/l
1.7
1.7
0.03
51
479
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
66
1.21
0.27
2.4
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
73
0.68
0.26
1.6
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
127
0.78
0.25
1.6
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
98
921
1.07
0.25
3.2
2.8
mosm/kgh2o
552.0
560.1
0.13
86
764
(3044640) Blood type and Crossmatch panel - Blood
158
1510
1.06
0.24
1.9
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
110
1162
0.94
0.24
2.0
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
171
1.17
0.23
2.9
2.5
u/ml
0.4
0.3
0.31
13
95
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.0
—
8.8
—
0
10
(3000494) Fungus identified in Specimen by Culture
49
534
0.91
0.22
1.5
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
95
0.73
0.22
1.1
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
248
1.13
0.22
2.7
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
334
3265
1.05
0.21
4.6
3.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
5.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
7.5
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
217
2239
0.95
0.21
3.2
4.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
29
324
0.89
0.21
2.6
2.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.0
—
283.0
—
0
7
(3000850) Epithelial cells [#/volume] in Urine
101
958
1.06
0.20
3.3
2.7
e6/l
7.6
4.7
0.67
91
836
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
14
0.00
0.20
0.0
6.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
14
0.00
0.20
0.0
6.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
122
1165
1.06
0.20
5.5
6.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
37
336
1.11
0.20
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
108
1.21
0.20
5.2
3.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
68
725
0.93
0.19
1.9
2.3
umol/l
13.5
12.6
0.36
60
676
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
99
1.22
0.19
1.5
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
128
1.18
0.18
4.3
3.0
mg/l
26.2
26.3
—
9
78
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
58
1.21
0.18
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
59
1.19
0.18
2.9
4.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
214
1.13
0.17
1.0
1.2
iu/ml
95.6
166.2
—
6
75
(3017181) Myelocytes/100 leukocytes in Blood
42
388
1.09
0.17
2.0
3.9
%
0.9
0.7
—
10
124
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
69
0.72
0.17
1.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
43
400
1.08
0.15
4.7
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
119
0.84
0.15
1.1
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
59
624
0.94
0.14
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
181
0.88
0.14
2.2
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
426
4308
0.97
0.13
3.9
3.9
mu/l
1.9
2.4
0.85
391
3804
(3007164) IgA [Mass/volume] in Serum or Plasma
74
708
1.05
0.12
1.4
1.5
g/l
2.2
2.6
1.28
47
424
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
43
404
1.07
0.12
3.0
2.2
ug/l
13.5
7.2
0.37
38
363
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
158
0.88
0.12
2.4
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
48
506
0.94
0.11
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
115
0.87
0.10
2.5
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
116
1192
0.97
0.10
4.4
3.3
estimate
0.0
0.0
0.50
38
374
(3030467) Casts [#/volume] in Urine by Automated count
139
1357
1.03
0.10
3.5
3.2
e6/l
0.6
0.6
0.04
108
1014
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
868
0.96
0.09
2.7
2.8
e6/l
1.3
1.0
0.43
59
515
(3025159) Blasts/100 leukocytes in Blood
36
340
1.06
0.09
2.1
4.0
%
0.0
0.1
—
8
94
(3022217) INR in Platelet poor plasma by Coagulation assay
64
663
0.96
0.08
29.7
29.9
inr
1.2
1.5
—
10
83
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
5
63
0.79
0.08
1.0
1.4
—
106.8
—
0
10
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
137
1.10
0.07
1.4
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
184
0.92
0.07
1.2
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
119
1.09
0.06
1.5
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
376
3785
0.99
0.05
6.1
7.3
u/l
72.2
80.5
5.25
348
3505
(3018095) Leukocytes [#/volume] in Urine
166
1682
0.98
0.05
4.0
3.7
e6/l
58.6
140.6
0.93
123
1197
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
110
1.09
0.05
2.2
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
148
1500
0.98
0.05
2.7
2.8
ng/l
1093.1
1573.3
0.92
121
1290
(3027945) Reticulocytes/100 erythrocytes in Blood
58
565
1.03
0.05
2.1
2.3
%
1.8
1.7
0.12
53
506
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
170
1.06
0.04
1.4
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
372
0.97
0.04
2.1
3.9
%
0.0
0.1
—
8
115
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
122
1.07
0.02
2.3
1.8
%
91.6
86.1
0.34
13
116
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
63
622
1.01
0.01
3.6
4.2
%
34.6
32.5
0.68
38
365
(3019150) Specific gravity of Urine by Refractometry
97
962
1.01
0.01
3.7
3.1
kg/l
1.0
1.0
0.81
22
131
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
104
1.06
0.01
1.5
1.5
nmol/l
52.5
40.8
0.69
11
99
(3023520) Reticulocytes [#/volume] in Blood
42
426
0.98
0.00
2.3
2.5
e9/l
61.3
66.6
0.67
32
322
(4034850)
16
155
1.03
0.00
4.0
7.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
13
134
0.97
0.00
3.3
2.1
g/l
3.4
3.6
0.19
13
127
(42529406) Shigella sp [Presence] in Stool by Culture
12
122
0.98
0.00
1.4
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
343
0.99
0.00
1.9
4.0
%
0.4
0.5
—
7
89
(36304419) Bacteria [Presence] in Urine
130
1295
1.00
0.00
3.5
3.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
121
0.99
0.00
1.4
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
3.4
—
6.5
—
0
8
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
52
0.96
0.00
1.2
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
1.8
—
0
9
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
36.9
—
0
6
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
30.1
—
0
5
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
49
1.02
0.00
1.2
3.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
65
0.92
0.00
1.2
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
64
640
1.00
0.00
1.5
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
70
1.00
0.00
1.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
370
1.00
0.00
4.9
3.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
91
0.99
0.00
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
160
1.00
0.00
4.9
4.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
120
1.00
0.00
1.4
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
55
0.91
0.00
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
86
0.93
0.00
1.4
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
1.6
—
6349.4
—
0
9
(1002224) Polysomnography panel
8
81
0.99
0.00
1.1
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
59
1.02
0.00
1.3
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_ALS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALS | 18.515 [14.27, 24.02] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.318 |
During the follow-up period (1.1.1998 — 31.12.2019), 2037 out of 2507 females with G6_ALS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_ALS | 9.357 [7.48, 11.7] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.04 |
During the follow-up period (1.1.1998 — 31.12.2019), 1983 out of 2612 males with G6_ALS died.
Mortality risk
Mortality risk for people of age
years, who have G6_ALS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 1.608% | 1.809% |
| 5 | 9.35% | 11.766% |
| 10 | 22.668% | 26.493% |
| 15 | 41.38% | 44.597% |
| 20 | 62.462% | 65.032% |
Relationships between endpoints
↥Index endpoint: G6_ALS – Motor neuron disease
GWS hits: 9
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data